Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S3122Referred to Committee

Better FDA Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-06
Introduced
3
Cosponsors
S
ⓘ
Type

Sponsor

Roger Marshall
Roger Marshall
Republican · KS · Senator
Votes with party: 77.0% (907 recorded votes)
Top industries funding sponsor:
  • Conservative Groups$1,092k

Full profile: /officials/M001198

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

3 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2025-11-06

Source: Congress.gov

Committee Activity

Previously

  • Senate Committee on Health, Education, Labor, and PensionsReferred To · 2025-11-06

Plain-English Summary

The legislation would make changes to how the Food and Drug Administration operates, though the specific reforms are not detailed in the available information. The bill would affect patients, pharmaceutical companies, and medical device manufacturers who interact with FDA approval processes. Once referred to the Senate committee, lawmakers will review the proposed modifications to FDA procedures and regulations.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S2403Retire through Ownership Act
    Enacted into Law · 2026-10-15
  • S5672Patients First Act of 2026
    Referred to Committee · 2026-09-30
  • S5228STOP the SWAMP Act
    Referred to Committee · 2026-08-04
  • S5156Retirement Simplification and Clarity Act
    Referred to Committee · 2026-07-29